Alentis Therapeutics AG
5 clinical trials · Sponsor
◉ Watch Alentis Therapeutics AG
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors (NCT07169734) | Alentis Therapeutics AG | 2025-08-26 |
| A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors (NCT06747585) | Alentis Therapeutics AG | 2024-12-16 |
| Study of ALE.C04 in Patients With Head and Neck Cancer (NCT06054477) | Alentis Therapeutics AG | 2023-10-30 |
| Rescue of Nephrons With ALE.F02 (RENAL-F02) (NCT06047171) | Alentis Therapeutics AG | 2023-09-07 |
| A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis (NCT05939947) | Alentis Therapeutics AG | 2023-04-01 |
Track Alentis Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.